4//SEC Filing
MCDONNELL BRENDAN 4
Accession 0001181431-05-039749
CIK 0000899394other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 12:13 PM ET
Size
8.6 KB
Accession
0001181431-05-039749
Insider Transaction Report
Form 4
MCDONNELL BRENDAN
Director
Transactions
- Sale
Common Stock
2005-07-11$7.84/sh−5,000$39,224→ 0 total - Exercise/Conversion
Common Stock
2005-07-11$2.25/sh+5,000$11,250→ 5,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-07-11−5,000→ 20,000 totalExercise: $2.25Exp: 2006-03-15→ Common stock (5,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2005
- [F2]The option vested and became exercisable over a period of three years, and was fully exercisable beginning April 1, 1999
Documents
Issuer
HOLLIS EDEN PHARMACEUTICALS INC /DE/
CIK 0000899394
Entity typeother
Related Parties
1- filerCIK 0001239651
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 12:13 PM ET
- Size
- 8.6 KB